China National Pharmaceutical Group is Among Suitors Exploring a Potential Acquisition of ... - Latest Tweet by Bloomberg

China National Pharmaceutical Group is among suitors exploring a potential acquisition of BBI Life Sciences, in a deal that could value the DNA synthesis products supplier at more than $1 billion, source says https://t.co/WDvrQPB5rU— Bloomberg (@business) July 7, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)